10.1007/s00109-011-0748-0 135 ShahidH.SinghJ
A comparison of semaglutide and tirzepatide Feature Semaglutide Tirzepatide FDA Approval Year 2017 (injection), 2020 (oral) 2022 Average Weight Loss ~1015% of body weight ~1520% of body weight Dosage Forms Weekly injection, oral tablet Weekly injection only Common Side Effects Nausea, vomiting, diarrhea, constipation Nausea, vomiting, diarrhea, constipation Frequency Weekly (injection), daily (oral) Weekly injection Cost (approximate) $900$1,200/month $1,000$1,300/month (Keep in mind that numbers are averages
Members: Be sure you are logged in to see your genotype data in the report section below
29, PP 11154-11165 [online] Available at: De Koning, E.J., Van der Zwaluw, N.L., Van Wijngaarden, J.P., Sohl, E., Brouwer-Brolsma, E.M., Van Marwijk, H.W.J., Enneman, A.W., Swart, K.M.A., Van Dijk, S.C., Ham, A.C., Van der Velde, N., Uitterlinden, A.G., Penninx, B